This is the latest episode of the free DDW podcast, “Is customisation healthcare’s secret weapon?”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW.
The articles are called “Optimising vaccine production through customisation” and “Exploring iPSCs for individual and population health applications”.
In the first article, “Optimising vaccine production through customisation”, John Yoshi Shyu, Ph.D. Corning Life Sciences offers an expert view on the topic. In the second article, Brad Hamilton, Founder and Chief Science Officer at GoodCell, examines the potential of induced Pluripotent Stem Cells.